P 2022

ヌクレアーゼの阻害剤としての置換アミノチアゾール

PARUCH, Kamil, Benoit Jean-Pierre CARBAIN, Štěpán HAVEL, Jiří DAMBORSKÝ, Jan BREZOVSKÝ et. al.

Basic information

Original name

ヌクレアーゼの阻害剤としての置換アミノチアゾール

Name (in English)

Substituted aminothiazoles as inhibitors of nucleases

Authors

PARUCH, Kamil (203 Czech Republic, belonging to the institution), Benoit Jean-Pierre CARBAIN (250 France, belonging to the institution), Štěpán HAVEL (203 Czech Republic, belonging to the institution), Jiří DAMBORSKÝ (203 Czech Republic, belonging to the institution), Jan BREZOVSKÝ (203 Czech Republic, belonging to the institution), Lukáš DANIEL (203 Czech Republic, belonging to the institution), Alexandra SISÁKOVÁ (703 Slovakia, belonging to the institution), Fedor NIKULENKOV (203 Czech Republic, belonging to the institution) and Lumír KREJČÍ (203 Czech Republic, belonging to the institution)

Edition

Number: JP7175031, Publisher: Japan Patent Office (JPO), Place of publication: Kasumigaseki Chiyoda-ku, Tokyo, Owner's name: Masarykova univerzita, 2022

Other information

Language

Japanese

Type of outcome

Patent

Field of Study

10401 Organic chemistry

Country of publisher

Japan

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14310/22:00128639

Organization unit

Faculty of Science

Keywords in English

DNA; propanamide; nuclease

Tags

International impact
Změněno: 14/2/2023 17:38, Mgr. Marie Šípková, DiS.

Abstract

V originále

本発明は、構造式(1)で表される化合物を提供する:【化1】 式中、R1、R2、R3、R4、R5、R6は、請求項で定義されている通りである。当該化合物はヌクレアーゼの阻害剤であり、特に、増殖性疾患、神経変性疾患、および他のゲノム不安定性関連疾患の治療および/または予防の方法において有用である。

In English

Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Links

EF16_025/0007381, research and development project
Name: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
LM2018130, research and development project
Name: Národní infrastruktura chemické biologie (Acronym: CZ-­OPENSCREEN)
Investor: Ministry of Education, Youth and Sports of the CR